Welcome to Medications.com

Efficacy of Aldara® (Imiquimod) for Treatment of Low-Risk Nodular ... - Cancer Consultants (press release)

Researchers from Germany have reported that Aldara® can eradicate 64% of low-risk nodular basal cell carcinomas. The details of this study were reported in ...

http://professional.cancerconsult... | Posted: Tue Nov 27 18:25:22 -0500 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea